Press Releases :: Viveve Medical, Inc. (VIVE)

A Global Women’s Intimate Health Company

Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study

Aug 7, 2018

Viveve to Announce Financial Results for Second Quarter 2018 and Host Conference Call

Aug 2, 2018

Viveve Reports Preliminary Second Quarter 2018 Revenue of $5.5 million

Jul 10, 2018

Viveve Submits VIVEVE II Clinical Study 30-Day Patient Safety Data to FDA

Jul 3, 2018

Viveve Reports Positive Six-Month Data from Stress Urinary Incontinence Feasibility Study

Jun 18, 2018

Viveve Announces Settlement of Patent Infringement Litigation with Thermi

Jun 4, 2018

Viveve to Present at Jefferies Global Healthcare Conference

May 29, 2018

Viveve Announces Initiation of VIVEVE II Clinical Study

May 16, 2018

Viveve Reports First Quarter 2018 Financial Results

May 10, 2018

Viveve Appoints Scott Durbin as Chief Executive Officer

May 10, 2018